tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 210 are a BUY (70%), 69 are a HOLD (23%), 21 are a SELL (7%).
Analyst Andrew Berens, currently employed at LEERINK, carries an average stock price target met ratio of 56.05% that have a potential upside of 36.09% achieved within 295 days. Previously, Andrew Berens worked at B. RILEY, MORGAN STANLEY.
Andrew Berens’s has documented 593 price targets and ratings displayed on 53 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive, Energy, Technology sectors.
Most recent stock forecast was given on TNGX, Tango Therapeutics at 08-Jun-2026.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Dec-2022
$31
$-6.9 (-18.21%)
$36
27 days ago
(11-Jun-2026)
8/8 (100%)
$2.28 (7.94%)
138
Buy Since 04-Dec-2021
$40
$2.1 (5.54%)
$41
1 months 9 days ago
(29-May-2026)
8/14 (57.14%)
$10.6 (36.05%)
528
Buy Since 05-Jan-2024
$36
$-1.9 (-5.01%)
$38
2 months 8 days ago
(30-Apr-2026)
8/10 (80%)
$8 (28.57%)
94
Buy Since 24-Feb-2025
$50
$12.1 (31.93%)
$65
2 months 18 days ago
(20-Apr-2026)
0/7 (0%)
$22.93 (84.71%)
Hold Since 03-May-2024
$32
$-5.9 (-15.57%)
$25
3 months 7 days ago
(01-Apr-2026)
6/6 (100%)
$-2.19 (-6.41%)
168
Which stock is Andrew Berens is most bullish on?
Which stock is Andrew Berens is most reserved on?
What Year was the first public recommendation made by Andrew Berens?
